Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-323845
Filing Date
2026-07-29
Accepted
2026-07-29 16:30:39
Documents
70
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q amrn-20260630.htm   iXBRL 10-Q 2552222
2 EX-10.1 amrn-ex10_1.htm EX-10.1 31736
3 EX-31.1 amrn-ex31_1.htm EX-31.1 13229
4 EX-31.2 amrn-ex31_2.htm EX-31.2 13905
5 EX-32.1 amrn-ex32_1.htm EX-32.1 14468
6 GRAPHIC img241760413_0.jpg GRAPHIC 287158
  Complete submission text file 0001193125-26-323845.txt   12523181

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT amrn-20260630.xsd EX-101.SCH 1450846
74 EXTRACTED XBRL INSTANCE DOCUMENT amrn-20260630_htm.xml XML 2753333
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 Ireland
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 Ireland 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21392 | Film No.: 261218115
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)